e319 and Luteolin share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.015 means 1% of the combined target set is bound by both compounds. The IDF-weighted score of 0.012 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do e319 and Luteolin have in common?
e319 and Luteolin share 2 molecular targets with a Jaccard similarity of 1%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can e319 and Luteolin be combined?
e319 and Luteolin share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: e319 or Luteolin?
Both e319 and Luteolin have substantial PubMed research. View their individual profiles for full evidence scores.